Geneva College launches Longevity PhD
Analysis based on 7 articles · First reported Apr 24, 2026 · Last updated Apr 24, 2026
The launch of the PhD program by Geneva College of Longevity Science and Ovidius University of Constanța signifies a formalization of longevity science, potentially accelerating research and development in the biotechnology and healthcare sectors. This could lead to new investment opportunities in companies focused on preventive medicine and aging biology.
The Geneva College of Longevity Science (GCLS), in academic partnership with Ovidius University of Constanța, announced the launch of the world's first PhD in Medicine with a specialization in Longevity Sciences. This four-year doctoral program aims to train physician-scientists and researchers in preventive, healthspan-oriented healthcare and the clinical translation of aging biology. Dominik Thor, President of Geneva College of Longevity Science, highlighted the program's role in building the necessary academic and research infrastructure for the field's long-term development. The program addresses the gap in formal academic pathways for longevity science, covering areas such as the biology of aging, biomarkers, preventive medicine, epidemiology, and ethical considerations.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard